WallStreetZenWallStreetZen

NASDAQ: ZVRA
Zevra Therapeutics Inc Stock Ownership - Who owns Zevra Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Zevra Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Neil F. McFarlanePresident and CEO2025-10-1019,500$10.82
$210.91kSell
Tamara A. FavoritoDirector2025-09-123,175$7.79
$24.72kBuy
Alvin ShihDirector2025-09-1220,000$7.89
$157.80kBuy
John B. BodeDirector2025-08-195,000$9.17
$45.82kBuy
Rahsaan ThompsonChief Legal Compliance2025-06-2624,000$9.21
$221.02kSell
Corey Michael WattonDirector2025-03-28300$7.84
$2.35kBuy
John B. BodeDirector2025-03-1910,000$7.96
$79.62kBuy
Neil F. McFarlanePresident and CEO2025-02-1430,544$8.05
$245.97kSell
Timothy J. SangiovanniSVP Finance Corp Controller2025-02-133,000$7.86
$23.59kSell
Joshua SchaferCCO EVP Bus. Development2025-02-1310,500$7.86
$82.53kSell

1 of 2

ZVRA insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ZVRA insiders and whales buy or sell their stock.

ZVRA Shareholders

What type of owners hold Zevra Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Delaware Street Capital Master Fund LP7.28%4,095,914$36.33MInsider
Blackrock Inc7.17%4,037,154$35.81MInstitution
Woodline Partners LP6.17%3,476,143$30.83MInstitution
Samuel J. Braun5.58%3,143,000$27.88MInsider
Vanguard Group Inc5.48%3,083,362$27.35MInstitution
Christal M. M. Mickle4.78%2,690,545$23.87MInsider
Adage Capital Partners GP LLC3.95%2,225,000$19.74MInstitution
Nantahala Capital Management LLC3.50%1,971,936$17.49MInstitution
Fmr LLC2.90%1,634,571$14.50MInstitution
State Street Corp2.54%1,427,291$12.66MInstitution

1 of 3

ZVRA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ZVRA70.82%22.18%Net SellingNet Selling
NBP11.20%0.00%
DNA9.27%90.73%Net SellingNet Selling
ENTA57.21%42.79%Net BuyingNet Selling
PRTA49.89%50.11%Net Selling
View Top Biotech Stocks

Zevra Therapeutics Stock Ownership FAQ

Who owns Zevra Therapeutics?

Zevra Therapeutics (NASDAQ: ZVRA) is owned by 70.82% institutional shareholders, 22.18% Zevra Therapeutics insiders, and 6.99% retail investors. Delaware Street Capital Master Fund LP is the largest individual Zevra Therapeutics shareholder, owning 4.10M shares representing 7.28% of the company. Delaware Street Capital Master Fund LP's Zevra Therapeutics shares are currently valued at $36.33M.

If you're new to stock investing, here's how to buy Zevra Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.